BEIJING, Feb. 8 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will participate at the following investor conferences in March 2010:
Investor Conference Date Location Rodman & Renshaw Annual March 7-9, 2010 The Regent Hotel, China Investment Beijing Conference Credit Suisse Asian March 22-26, Conrad Hong Kong Investment Conference 2010 2010
The Company's Chief Financial Officer, Mr. Sam Tsang, will discuss the Company's strategies, operations, growth opportunities as well as its published financial results to date with institutional investors during the two investor conferences.
About China Medical Technologies, Inc.
China Medical Technologies, Inc. is a leading China-based advanced IVD company using Fluorescent in situ Hybridization (FISH) technology, Surface Plasmon Resonance (SPR) technology and Enhanced Chemiluminescence Immunoassay (ECLIA) technology to develop, manufacture and distribute diagnostic products for detecting and monitoring various cancers, diseases and disorders. For more information, please visit http://www.chinameditech.com .
For more information, please contact: Winnie Yam Tel: +852-2511-9808 Email: IR@chinameditech.com
SOURCE China Medical Technologies, Inc.
|SOURCE China Medical Technologies, Inc.|
Copyright©2010 PR Newswire.
All rights reserved